CIM
DGX icon

Contravisory Investment Management’s Quest Diagnostics DGX Stock Holding History

Contravisory Investment Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,628
Closed -$882K – 379
2025
Q3 		$882K Buy
4,628
+1,550
+50% +$275K 0.17% 86
2025
Q2 		$553K Buy
+3,078
New +$535K 0.11% 130
2023
Q3 		– Sell
-3,064
Closed -$431K – 340
2023
Q2 		$431K Buy
+3,064
New +$422K 0.11% 129
2020
Q2 		– Sell
-2,997
Closed -$241K – 272
2020
Q1 		$241K Sell
2,997
-57
-2% -$5.9K 0.11% 108
2019
Q4 		$326K Buy
3,054
+44
+1% +$4.59K 0.12% 116
2019
Q3 		$322K Buy
+3,010
New +$309K 0.12% 107
2017
Q4 		– Sell
-2,826
Closed -$265K – 458
2017
Q3 		$265K Buy
2,826
+5
+0.2% +$531 0.09% 109
2017
Q2 		$314K Buy
2,821
+103
+4% +$10.9K 0.11% 58
2017
Q1 		$267K Buy
2,718
+2,345
+629% +$224K 0.09% 66
2016
Q4 		$34K Buy
373
+151
+68% +$13K 0.01% 137
2016
Q3 		$19K Buy
+222
New +$18.6K 0.01% 120
2015
Q4 		– Sell
-3,396
Closed -$209K – 216
2015
Q3 		$209K Sell
3,396
-392
-10% -$27.4K 0.05% 64
2015
Q2 		$275K Hold
3,788
– – 0.06% 54
2015
Q1 		$291K Sell
3,788
-390
-9% -$27.9K 0.06% 50
2014
Q4 		$280K Buy
+4,178
New +$264K 0.06% 54

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Contravisory Investment Management's DGX Position: Q4 2025 in Review

Contravisory Investment Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 4,628 shares — an estimated $882K sold.

Contravisory Investment Management first reported a position in DGX in Q4 2014 and held it in 15 quarters. The position peaked at $882K in Q3 2025. 1,050 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Contravisory Investment Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Contravisory Investment Management sold 4,628 Quest Diagnostics shares in Q4 2025, an estimated $882K.
  • Contravisory Investment Management first reported a position in Quest Diagnostics in Q4 2014 and held it in 15 quarters.
  • Contravisory Investment Management's Quest Diagnostics position peaked at $882K in Q3 2025.
  • 1,050 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Contravisory Investment Management's 13F filing for Q4 2025, filed 12 Jan 2026.